Cargando…
The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine
In the past decade, the federal government has frequently investigated and prosecuted pharmaceutical manufacturers for illegal promotion of drugs for indications not approved by the Food and Drug Administration (FDA) (“off-label” uses). State governments can choose to coordinate with the federal inv...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384770/ https://www.ncbi.nlm.nih.gov/pubmed/28388667 http://dx.doi.org/10.1371/journal.pone.0175313 |